Brent Saunders – pharmaceutical daily

November 2, 2016 Off

Allergan announces $10 B accelerated share repurchase, initiation of cash dividend in 2017

Allergan has completed its initial $5 billion in share repurchases under its previously announced share repurchase program…

November 23, 2015 Off

Pfizer and Allergan in $160B merger

By Dino Mustafić

Pfizer and Allergan have entered into a definitive merger agreement under which Pfizer will combine with Allergan in a transaction valued at about $160 billion.

October 19, 2015 Off

Allergen wraps up AqueSys buy (Including $300M up-front payment)

By Dino Mustafić

Allergan plc has completed the acquisition of AqueSys, Inc. a clinical-stage medical device company focused on developing ocular implants that…